Kneu Health Secures $2 Million Investment from Cedars-Sinai and Oxford Science Enterprises to Revolutionize Neurology Care
Backing & Validation: Oxford Research & Clinical Evidence
January 29, 2025
Kneu Health, a pioneering neurology health-tech company spin-out from the University of Oxford, has secured $2 million in co-investment from Cedars-Sinai and Oxford Science Enterprises (OSE). This funding marks the launch of a groundbreaking partnership between the two organizations to co-build and co-invest in health-tech startups, accelerating their growth in the U.S. and U.K. markets.
The investment will support Kneu Health's expansion into the U.S., starting with a six-month pilot program at Cedars-Sinai. This milestone enables Kneu Health to bring its innovative platform, designed for Parkinson's disease and dementia care, to a broader audience.
Caroline Cake, CEO of Kneu Health, shared: "Our goal is to change what's possible in neurology care. Our partnership with Cedars-Sinai and OSE shows the growing global commitment to improving care for Parkinson's disease and dementia. Together, we're building a future where technology helps patients, care givers and doctors manage these challenging conditions."
Backed by over a decade of Oxford research and clinical validation, Kneu Health empowers clinicians, caregivers, and patients alike. The platform's patient-centric design supports improved symptom monitoring, tailored care plans, and proactive clinical interventions. By integrating patient insights with streamlined clinician workflows, Kneu Health is helping preserve independence and enhance the quality of life for those affected by neurodegenerative conditions.
Dr John Glaser, Chairman of the Board at Kneu Health, said: Neurological disease has claimed my father and my brother. The Kneu Health technology will enable clinicians, patients and family caregivers to take major steps forward in managing these diseases. I am delighted to see the resources and talents of Cedars-Sinai, Oxford Science Enterprises and Kneu Health brought to bear to materially advance the management of the health and healthcare of families like mine.
The pilot at Cedars-Sinai will bring Kneu Health's proven approach to 150 patients, paving the way for broader adoption in the U.S. market and strengthening Kneu Health's mission to transform neurology care on a global scale. Kneu Health is more than a technology—it's a movement to ensure every patient, regardless of location, can access the high-quality care they deserve.
About Kneu Health
Kneu Health is pioneering a new model of precision neurology for Parkinson's and dementia: care that is proactive, compassionate, and designed for the realities of everyday life. Built on one of the most advanced longitudinal datasets in Parkinson's care — the Oxford Parkinson's Disease Centre Discovery Cohort — Kneu's smartphone-based platform turns structured at-home assessments into actionable insights, enabling clinicians to detect decline earlier and act before symptoms escalate. The technology analyzes speech, movement, memory, and cognition in just minutes a day, using trained models to generate predictive scores and digital biomarkers that inform treatment and care. Kneu is working with leading U.S. health systems to expand access, ease workforce strain, and set a new standard for brain health monitoring.
About Oxford Science Enterprises
Oxford Science Enterprises (OSE) is an independent, billion-pound investment company created to found, fund, and build transformational businesses through its unique partnership with the University of Oxford. With a focus on Life Sciences, Health Tech, and Deep Tech, OSE has invested over £2.5 billion in groundbreaking companies addressing some of the world's greatest challenges.
For more information, visit www.oxfordscienceenterprises.com.
About Cedars-Sinai
Cedars-Sinai is a leading nonprofit healthcare organization based in Los Angeles, California, known for its dedication to providing high-quality patient care, innovative research, and advanced medical education. Through strategic initiatives like this partnership, Cedars-Sinai aims to advance patient-centered health-tech solutions and improve healthcare outcomes globally..
Discover more at www.cedars-sinai.org.